PREVENTION OF LOW-DOSE ACETYLSALICYLIC ACID-ASSOCIATED GASTRIC/DUODENAL ULCERS WITH ESOMEPRAZOLE 20 MG AND 40 MG ONCE DAILY IN PATIENTS AT INCREASED RISK OF ULCER DEVELOPMENT: A RANDOMISED CONTROLLED TRIAL (OBERON)

(1) Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, United States

(2) Louis Leipoldt Medical Centre, Cape Town, South Africa

(3) Group Practice, Ludwigshafen, Germany

(4) Tabor Hospital, Tabor, Czech Republic

(5) 110 Military Hospital with Pryzchodnia, Elblag, Poland

(6) AstraZeneca R&D, Mölndal, Sweden



This item was part of the OESOPHAGEAL, GASTRIC AND DUODENAL DISORDERS II session at Gastro 2009 UEGW/WCOG London (17th UEGW)